Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/eurpub/ckab002 http://scihub22266oqcxt.onion/10.1093/eurpub/ckab002 33585912!7928868!33585912     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33585912&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Public+Health 2021 ; 31 (2): 283-285 Nephropedia Template TP {{tp|p=33585912|t=2021. The hydroxychloroquine debate: a therapeutic dilemma for general practitioners |pdf=|usr=}}{{33585912}} gab.com Text The hydroxychloroquine debate: a therapeutic dilemma for general practitioners JO: Eur J Public Health http://www.kidney.de/pget.php?&tw=1&pmid=33585912 #FOAvip France has been at the epicenter of the worldwide debate about hydroxychloroquine, as the main advocacy for its use to treat COVID-19 comes from a research unit led by Didier Raoult in Marseille. Among a national panel of 2940 general practitioners, we found that physicians in the areas most strongly affected by the epidemic or closest to the epicenter of the controversy reported that the hydroxychloroquine debate had made it difficult for them to deal with patients' treatment requests. Their adherence to official recommendations was also lower. It will be necessary to examine the conditions producing so strong a conflict. Twit Text FOAVip The hydroxychloroquine debate: a therapeutic dilemma for general practitioners ????Eur J Public Health http://www.kidney.de/pget.php?&tw=1&pmid=33585912 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33585912 #FOAvip English Wikipedia <ref>{{Cite pmid|33585912}}</ref> The hydroxychloroquine debate: a therapeutic dilemma for general practitioners #MMPMID33585912 Lutaud R; Scronias D; Ward J; Verger P Eur J Public Health 2021[Apr]; 31 (2): 283-285 PMID33585912show ga France has been at the epicenter of the worldwide debate about hydroxychloroquine, as the main advocacy for its use to treat COVID-19 comes from a research unit led by Didier Raoult in Marseille. Among a national panel of 2940 general practitioners, we found that physicians in the areas most strongly affected by the epidemic or closest to the epicenter of the controversy reported that the hydroxychloroquine debate had made it difficult for them to deal with patients' treatment requests. Their adherence to official recommendations was also lower. It will be necessary to examine the conditions producing so strong a conflict. |*COVID-19 Drug Treatment[MESH] |*COVID-19/epidemiology[MESH] |*General Practitioners/psychology/statistics & numerical data[MESH] |*Hydroxychloroquine/therapeutic use[MESH] |Female[MESH] |France/epidemiology[MESH] |Guideline Adherence/statistics & numerical data[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Physician-Patient Relations[MESH]The hydroxychloroquine debate: a therapeutic dilemma for general pract(epmc).pdf DeepDyve Pubget Overpricing